news Cilcare completes a €40M series A Learn More > 4 December 2024 10 years of innovation for Making Hearing A Priority Learn More > 2 December 2024 Cilcare appoints Mélanie Berta as Project Manager, Drug Development Learn More > 7 November 2024 Cilcare appoints Patricia Machado as Early Drug Development & Pipeline Director Learn More > 30 September 2024 Cilcare wins prestigious Hearing Technology Innovator Award for CIL001 Learn More > 25 September 2024 Cilcare Awarded €4.2 million to combat the global epidemic of hidden hearing loss, as part of the France 2030 Plan’s “i-Démo” call for projects Learn More > 27 June 2024 Cilcare and Shionogi announce exclusive Option Agreement for innovative hearing disorder treatment Learn More > 6 June 2024 Cilcare appoints Naimi Missoum as Chief Medical Officer Learn More > 23 May 2024 Cilcare-CBSET’s review article on ototoxicity published in Frontiers in Molecular Neuroscience ! Learn More > 21 May 2024 « Previous Page1 Page2 Page3 Page4 Page5 … Page27 Next »
Cilcare appoints Patricia Machado as Early Drug Development & Pipeline Director Learn More > 30 September 2024
Cilcare wins prestigious Hearing Technology Innovator Award for CIL001 Learn More > 25 September 2024
Cilcare Awarded €4.2 million to combat the global epidemic of hidden hearing loss, as part of the France 2030 Plan’s “i-Démo” call for projects Learn More > 27 June 2024
Cilcare and Shionogi announce exclusive Option Agreement for innovative hearing disorder treatment Learn More > 6 June 2024
Cilcare-CBSET’s review article on ototoxicity published in Frontiers in Molecular Neuroscience ! Learn More > 21 May 2024
